A primary oseltamivir-resistant mutation in influenza hemagglutinin and its implications for antiviral resistance surveillance

Lei Zhang, Yuekun Shao, Xiaohui Zou, Yingzi Cui, Shenyang Ding, Yuantao Chen, Qian Wu, Shengrui Mu, Xiong Li, Qiuxian Yang, Bin Cao, Tao Deng · 2025

Read A primary oseltamivir-resistant mutation in influenza hemagglutinin and its implications for antiviral resistance surveillance by Lei Zhang, Yuekun Shao, Xiaohui Zou, Yingzi Cui, Shenyang Ding, Yuantao Chen, Qian Wu, Shengrui Mu, Xiong Li, Qiuxian Yang, Bin Cao, Tao Deng (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12749811.txt.

Description

Lei Zhang and co-authors show that a flu virus can gain drug resistance through a change in its coat protein, not just the protein the drug targets, in a study from 2025. The drug is the most used flu drug in the world, and watch lists track resistance in its target protein.

In lab passages under drug pressure, the virus picked up coat changes on their own. One such change has spread in real flu strains since a few years back. That change also boosted resistance from a known target change when both sat in one virus. The authors urge world watch lists to track coat changes too.

Catalog record

CREATORLei Zhang, Yuekun Shao, Xiaohui Zou, Yingzi Cui, Shenyang Ding, Yuantao Chen, Qian Wu, Shengrui Mu, Xiong Li, Qiuxian Yang, Bin Cao, Tao Deng
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12749811

Browse the full library · About the Tower of Babel